1) Markowitz LE, Orenstein WA: Measles Vaccines. Pediatr Clin North Am 37:603-649, 1990 2) Rosenthal SR, Clements CJ: Two dose measles vaccination schedules. Bull WHO 71:421-428, 1993 3) Hopkins DR, Hinman AR, Koplan JP, Lane JM: The case for global measles eradication. Lancet 6:1396-1398, 1982 4) º¸°Ç »çȸºÎ: Á¦2Á¾ ÁÖ¿ä Àü¿°º´ ÀÌȯÀ². º¸°Ç»çȸÅë°è¿¬º¸. 1990 p16-17 5) º¸°Ç »çȸºÎ: Á¦2Á¾ ÁÖ¿ä Àü¿°º´ ÀÌȯÀ². º¸°Ç»çȸÅë°è¿¬º¸. 1994 p18-19 6) ±¹¸³º¸°Ç¿ø: Á¦1, 2Á¾ ¹ýÁ¤Àü¿°º´ÀÇ ¿ù°£ ±¹³» Åë°è. °¨¿°º´¹ß»ýÁ¤º¸ 6:33, 1995 7) ¼Õ¿µ¸ð, ȫâȣ, À̽±Ô: ÃÖ±Ù ¼¿ï °³²Áö¿ª¿¡¼ À¯ÇàÇÑ È«¿ªÀÇ ¹ß»ý ¾ç»ó, 1989-1990. ´ëÇÑÀÇÇÐÇùȸÁö 34:960-968, 1991 8) À̱ÝÀÚ, ÀÌ°ÇÈñ À±Çý¼±: È«¿ª Ç×ü°¡ ÃøÁ¤¿¡ ÀÇÇÑ È«¿ª ¿¹¹æ ¹é½ÅÀÇ Á¢Á¾ ½Ã±â¿Í È¿°ú¿¡ °üÇÑ ¿¬±¸. ¼Ò¾Æ°ú 34:1201-1210, 1991 9) ÃÖ»ó¹¬, ¿Àâ¼ö, ¹Ú»óö, ±èâÈÖ, ÀÌ»óÁÖ: Ç÷ûÇÐÀûÀ¸·Î Áø´ÜµÈ È«¿ª¿¡ ´ëÇÑ °íÂû. ¼Ò¾Æ°ú 35:508-514, 1992 10) Kim SK, Son BK, Chung CY, Ahn YM, Park CY, Lee HJ: Efficcy of measles vaccine during the 1993 measles epidemic in korea Pediatr Infect Dis J 14:346-349, 1995 11) ¼ÛÀ±¹Ì, À̽ÂÈÆ, ¼È«°ü, ȲÀÎÈ«, ÇãºÀ¿, ÀÓÇö¼ú: ÀϺΠµµ½ÃÁö¿ª¿¡¼ÀÇ È«¿ª ¹ß»ý¿¡ °üÇÑ ¿ªÇÐÁ¶»ç. °¡Á¤ÀÇ 11:20-29, 1990 12) ´ëÇѼҾưúÇÐȸ °¨¿°À§¿øȸ, Ãֿ빬, ±èâÈÖ, ¼Á¤±â, ¼Õ¿µ¸ð, ¿À¼ºÈñ, ÀÌȯÁ¾, ÀüÁ¤½Ä: ¿ì¸®³ª¶ó¿¡¼ ÇöÀç ½ÃÇàµÇ°í ÀÖ´Â È«¿ª ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ÀçÆò°¡. ¼Ò¾Æ°ú 34:435-440, 1991 13) ´ëÇѼҾưúÇÐȸ °¨¿°À§¿øȸ, ¼Õ¿µ¸ð, ±èâÈÖ, ¿À¼ºÈñ, ÀÌȯÁ¾, ¹ÚÁ¾¿µ, ÀüÁ¤½Ä, ½Å»ó¸¸: ÃÖ±ÙÀÇ È«¿ª À¯Çà¿¡ ´ëÇÑ °íÂû. ¼Ò¾Æ°ú 37:289-291, 1994 14) Reyes MA, Vorrero MF, Roa J, Bergonzoli G, Saravia NG: Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 6:848-851, 1987 15) Linnemann CC, Rotte TS, Schife GM, Youtsey JL: A seroepidemiologic study of a measles epidemic in a highly immunized populatin. Am J Epidemiol 95:238-246, 1972 16) Schluederberg A, Lamm SH, Landrigan PJ, Black FL: Measles immunity in children vaccinated before one year of age. Am J Epidemiol 97:402-409, 1973 17) Cherry JD, Feigin RD, Lobes LA, Hinthorn DR, Shackelford PG, Shirley RH, Lins RD, Choi SC: Urban measles in the vaccine ear. Clinical, epidemiologic, and serologic study. J Pediatr 81:2217-230, 1972 18) Linnemann CC, Hegg ME, Rotte TC, Phair JP, Schiff GM: Measles IgM response during reinfection of previously vaccinated children. J Pediatr 82:798-801, 1973 19) Mathias RG, Meekison WG, Arcand TA, Schechter MT: The role of secondary vaccine failure in measles outreakes. Am J Public Health 79:475-478, 1989 20) Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP: Mild measles and secondary vaccine failure during a sustained outbarake in a highly vaccinated population. JAMA 263:2467-2471, 1990 21) Ozanne G, D’Halewyn M: Secondary immune response in a vaccinated population during a large measles epidemic. J Clinic Micro 30:1778-1782, 1985 22) Brown P, Gajdusek DC, Tsai T: Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin populations with Edmonston B vaccine. Am J Epidemiol 90:514-518, 1969 23) Krugman S: Present status of measles and rubella immunization in United States. A medical progress report. J Pediatr 90:1-12, 1977 24) Miller C: Live measles vaccine; a 21 year follow up. Br Med J 295:22-24, 1987 25) Markowitz LE, Sepulveda J, Diaz-Ortega JL, Valdespino JL, Albrecht P, Zell ER, Stewart J, Zarete ML, Bernier RH: Immunization of six-month old infants with different doses of Ed-monston-Zagreb and Schwarth measles vaccine. N Engl J Med 322:580-587, 1990 26) Hull HF, Montes JM, Hays PC, Lucero RL: Risk factors for measles vaccine failure among immunized students. Pediatrics 76:518-523, 1985 27) King JC, Lichestein R, Feigelman S, Luna C, Permutt TJ, Patel J: Measles, mumps, and rubella antibodies in vaccinated Baltimore children. Am J Dis Child 147:558-560, 1993 28) Â÷°æÈÆ, Á¤Àº°æ, ¹®°æ·¡, ±è°©½Â, ¹Ú»ó±â, ¹Ú¿µºÀ: È«¿ª¹é½Å Á¢Á¾ÈÄ Ç×ü°¡ÀÇ ¾çÀü·ü¿¡ °üÇÑ °íÂû. ¼Ò¾Æ°ú 34:1080-1085, 1991 29) ±è¹ÎÇý, ÀÌÁöÀº, ¼Á¤¿Ï, È«¿µ¹Ì, ±è°æÈñ: ¼Ò¾Æ ¿¬·É¿¡ µû¸¥ È«¿ª Ç×ü°¡ÀÇ º¯µ¿¿¡ °üÇÑ ¿¬±¸. ¼Ò¾Æ°ú 34:1519-1525, 1991 30) Cutts FT, Markowitz LE: Successes and failure in measles control. J Infect Dis 170(Suppl 1): S32-41, 1994 31) Gustafson TL, Lievens AW, Brunell PA, Meollenberg RG, Christopher BS, Buttery MG, Sehulster SM: Measles outbreak in a fully immunized secondary-school population. N Engl J Med 316:771-774, 1987 32) 33) Markowitz LE, Albreit P, Orenstein WA, Lett SM, Pugliese TJ, Farrell D: Persistence of measles antibody after revaccination. J Infect Dis 166:205-208, 1992 34) Matson DO, Byington C, Canfield M, Albrecht P, Feign RD: Investigation of a measles outbrake in a fully vaccinated school population including serum studies before and after revaccination. Pediatr Infect Dis J 12:292-299, 1993 35) Cohn ML, Robinson ED, Faerber M, Thomas D, Geyer S, Peters S, Martin M, Martin A, Sobel D, Jones R, Larkin L, Richert JR: Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults. Pediatr Infect Dis J 13:34-38, 1994 36) Nkowane BM, Bart SW, Orenstein WA, Baltier M: Measles outbeak in a vaccinated school population: In previously vaccinated children. Am J Public Health 77:434-438, 1987 37) Orenstein WA, Albrecht P, Herrman KL, Bernier R, Bart KJ, Rovira EZ: Evaluation of low levels of measles antibody: the plaque neutralization test as a measure of prior exposure to measles virus. J Infect Dis 155:146-149, 1986 38) Hethcote HW, Measles and rubella in the United States. Am J Epidemiol 177:2-13, 1983 39) Hutchins Ss, Markowitz LE, Mead P, Mixon D, Sheline J, Greenberg N, Preblud SR, Orenstein WA, Hull HF: A school-based measles outbreak: The effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol 132:157-168, 1990 40) Markowitz LE, Katz SL: Measles vaccine: In Plotkin SA, Mortimer EA Jr (Eds): Vaccine. 2 nd Ed. Philadelphia, WB Saunders Co, 1994 p229-276 41) Whittler RR, Veit BC, Mclntyre S, Schydlower M: Measles revaccination response in a school age populaton. Pediatrics 88:1024-1030, 1991
|